Amgen Inc. (AMGN): Hedge Fund Interest and Strong Pipeline Support Moderate Buy Rating

Amgen Inc. (AMGN): Hedge Fund Interest and Strong Pipeline Support Moderate Buy Rating

A recent article ranks Amgen Inc. (NASDAQ:AMGN) as the 9th best healthcare stock to buy according to hedge funds. The healthcare sector is growing, with increasing healthcare spending and advancements in AI technology. Amgen's revenue growth is strong, driven by innovative medicines and acquisitions.

Read More

Did you find this insightful?